Ayahuasca triggers a cascade of changes in the brain, from flooding serotonin receptors with a powerful psychedelic compound to quieting the brain networks responsible for your sense of self. Its effects begin within about 30 minutes of drinking the brew, peak over the next few hours, and can last four to six hours total. But some of the most interesting changes, including shifts in brain structure and the growth of new neural connections, appear to extend well beyond the experience itself.
How Ayahuasca Gets Past the Brain’s Defenses
Ayahuasca is a two-part system, and understanding why matters. The brew combines DMT, a potent psychedelic compound, with a vine containing chemicals called beta-carbolines (primarily harmine and harmaline). DMT alone is almost useless when swallowed because an enzyme in your gut called MAO-A breaks it down before it ever reaches your bloodstream. The beta-carbolines temporarily block that enzyme, allowing DMT to survive digestion and build up to concentrations high enough to cross the blood-brain barrier and produce psychedelic effects.
Animal studies have formally confirmed this mechanism. When harmine was given alongside DMT, it blocked the formation of DMT’s main breakdown product in the brain while substantially increasing the amount of DMT available to act on neurons. This is, in essence, ayahuasca’s core trick: one plant protects the other plant’s active ingredient long enough for it to reach the brain.
What DMT Does Once It Reaches Your Neurons
Once in the brain, DMT acts as a partial activator of serotonin receptors, most importantly the 5-HT2A receptor. Activation of this receptor is considered necessary for the hallucinations and perceptual shifts that define the psychedelic experience, though it’s not the only receptor involved. DMT also binds to at least eight other serotonin receptor subtypes, with varying degrees of strength.
The timeline differs sharply depending on how DMT enters the body. When injected intravenously in clinical studies, DMT reaches peak plasma concentrations in under three minutes and wears off within 30 minutes. Ayahuasca slows this dramatically. Because DMT is absorbed through the gut and the beta-carbolines gradually protect it from breakdown, the experience builds over roughly two hours and sustains itself for four to six hours. Peak plasma DMT levels with ayahuasca-like formulations have been measured around 33 ng/mL, compared to over 60 ng/mL with intravenous injection, but the exposure lasts far longer.
Quieting the Default Mode Network
One of ayahuasca’s most well-documented effects is a significant decrease in activity across the default mode network (DMN), a set of brain regions that are most active when you’re not focused on the outside world. The DMN handles self-referential thinking: daydreaming, ruminating, planning, and maintaining your autobiographical sense of who you are. Brain imaging studies show ayahuasca reduces activity in the DMN’s two major hubs, the posterior cingulate cortex and the medial prefrontal cortex, with reductions reaching statistical significance across most parts of the network.
Connectivity within these hubs also drops. The posterior cingulate cortex, which normally communicates tightly with other DMN regions, becomes functionally less connected during the ayahuasca state. This disruption is closely linked to what people describe as ego dissolution, the feeling that the boundary between yourself and the world is softening or disappearing. Researchers have described the subjective shift as moving from being an actor in your own story to being an attentive spectator. Similar DMN suppression has been observed with psilocybin, during deep meditation, and in certain stages of sleep.
Visual Cortex Activation and Internal Imagery
Ayahuasca is known for producing vivid, complex visual experiences even with eyes closed. Brain imaging helps explain why. During the ayahuasca state, the primary visual cortex (the brain’s first processing station for visual information) shows increased activity and connectivity, even in the absence of external visual input. This area also forms unusual connections with attentional networks that don’t normally communicate with it during rest.
The result is that the brain’s visual processing machinery essentially starts generating images from internal sources rather than from the eyes. This likely accounts for the elaborate, often dreamlike visions people report: geometric patterns, landscapes, entities, and scenes that feel as vivid as waking perception. These changes in visual, salience, and default mode areas together create the layered, immersive quality of the ayahuasca experience.
Emotional Processing and the Amygdala
Ayahuasca doesn’t just alter perception. It also reshapes how the brain handles emotional information. Imaging studies show that ayahuasca dampens activity in the amygdala, the brain’s threat-detection center, while simultaneously boosting activation in the insular cortex and prefrontal cortex. In practical terms, this means the brain’s alarm system quiets down while the regions responsible for conscious awareness and emotional regulation become more active. People in these studies reported reduced anxiety alongside this neural shift.
Chronic administration studies in animals tell a complementary story. Repeated ayahuasca exposure increased markers of neuronal activation in the amygdala, prefrontal cortex, and hippocampus, suggesting enhanced connectivity and plasticity across the brain’s emotional circuitry. Ayahuasca has also been found to reduce stress-induced inflammation and oxidative damage in the hippocampus and prefrontal cortex, two regions heavily implicated in depression. These combined effects may help explain why many people describe ayahuasca experiences as emotionally clarifying or therapeutic.
Neuroplasticity: Growing New Connections
Beyond its acute effects, ayahuasca appears to promote the brain’s ability to rewire itself. One key marker is BDNF, a protein that supports the survival of existing neurons and encourages the growth of new synaptic connections. In animal studies, high doses of ayahuasca increased BDNF protein levels in the hippocampus, a region critical for memory and learning. In clinical studies with people experiencing treatment-resistant depression, blood levels of BDNF rose 48 hours after a single ayahuasca session, and those increases correlated with reductions in depressive symptoms.
The picture isn’t perfectly consistent. At least one follow-up study in humans found no significant change in serum BDNF levels 48 hours after a single dose. But laboratory studies on neural cells suggest that ayahuasca, at low doses, can directly stimulate the proliferation of neural progenitor cells, the precursors to new neurons. DMT itself appears to have dose-dependent neuroprotective properties. Harmine, the primary beta-carboline in the brew, also independently modulates mitochondrial function and oxidative stress in the prefrontal cortex and hippocampus, offering another potential pathway for its effects on brain health.
Structural Changes in Long-Term Users
People who use ayahuasca regularly over years show measurable differences in brain structure compared to non-users. Early studies of members of Santo Daime, a Brazilian religious tradition that uses ayahuasca sacramentally, found thinning of the posterior cingulate cortex, the same DMN hub that ayahuasca acutely suppresses, alongside thickening of the structure connecting the brain’s two hemispheres.
More recent research has added nuance. One study found that long-term users actually showed cortical thickening in midline structures and superior frontal regions, including the posterior cingulate and medial frontal cortex, along with sparse thinning in parietal and occipital areas. These users also exhibited altered patterns of structural similarity across sensorimotor, temporal, and prefrontal regions. The direction of these changes is still being worked out, but the consistent finding is that repeated ayahuasca use leaves a structural signature on the brain, particularly in areas involved in self-awareness, attention, and sensory processing.
Safety Profile and Dangerous Interactions
Ayahuasca’s safety has been demonstrated across multiple clinical trials involving different dosages and repeated administrations, as well as in naturalistic ceremonial settings. Long-term use does not appear to cause neurotoxic damage. Persistent perceptual disturbances, sometimes called flashbacks, are rarely reported with ayahuasca compared to other psychedelics. While physical side effects like nausea and vomiting are extremely common during the experience, and challenging psychological episodes do occur, they are not generally severe. Most people who attend ceremonies continue to do so, suggesting they find the benefits worth the discomfort.
The most serious safety concern is drug interactions. Because ayahuasca contains MAO inhibitors, combining it with medications that increase serotonin levels can trigger serotonin toxicity, a potentially life-threatening condition. The highest-risk medications are SSRIs and SNRIs, the most commonly prescribed antidepressants: citalopram, escitalopram, fluvoxamine, fluoxetine, paroxetine, and sertraline. Case reports have documented serotonin toxicity in individuals who took ayahuasca while on fluoxetine (Prozac), and in one case involving fluoxetine combined with quetiapine. Other MAO inhibitors, including prescription medications like tranylcypromine, isocarboxazid, phenelzine, and selegiline, also pose serious risks. Anyone taking serotonergic medications needs to be aware that these interactions can be dangerous even days or weeks after stopping certain drugs, due to their long half-lives.